期刊文献+

新型内毒素特异吸附血液净化材料的制备与性能研究 被引量:1

Study on Preparation and Property of a New Adsorbent for Endotoxin Removal in Blood Purification
原文传递
导出
摘要 本研究目的是制备一种带有肝素(heparin)分子臂和多黏菌素B(PMB)配基的用于清除内毒素的血液净化吸附材料,探讨其在内毒素血症治疗方面的潜在应用价值。首先采用氯甲基树脂(PS)为载体,经乙二胺活化后引入肝素分子臂,戊二醛将PMB配基固定于吸附剂;荧光标记内毒素(FITC-LPS)体外静态吸附实验直接观察材料吸附性能,内毒素体外静态吸附实验测定其吸附量和吸附率,并对吸附剂血液相容性进行了评价。结果表明,吸附剂在2h左右能够达到吸附平衡,对脂多糖(LPS)的去除率能够达到70%以上,对血细胞和血浆蛋白的吸附率分别小于10%和20%。吸附剂对于LPS具有高选择性及高吸附量,并具有良好的生物相容性,在内毒素血症治疗方面具有一定的临床应用前景。 In order to remove the endotoxin from the blood of endotoxemia patients, we prepared a new adsorbent with heparin space arm and polymyxin B (PMB) ligand. The carrier of chloromethyl polystyrene resin was activated and heparin space arm was grafted, and then PMB ligand was immobilized onto adsorbent with glutaraldehyde. We employed in vitro FITC-lipopolysaccharide (FITC-LPS) static adsorption to characterize the adsorption properties on the adsorbent, and conducted in vitro lipopolysaccharide (LPS) static adsorption to measure quantitavely the adsorp- tion capacity and rate, and then evaluated the blood compatibility. The in vitro static adsorption indicated that the adsorbent had the removal rate of LPS above 70~ with the adsorption equilibrium time for 2 hours. Blood compati- bility experiment showed that the adsorbent had little negative effects on blood cells and plasma protein, and their ad- sorption rates were less than 10% for hemocytes and 20~ for plasma protein respectively. This adsorbent exhibited high selectivity, high adsorption capacity and good biocompatibility, and presented a promising clinical application in the treatment of endotoxemia.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2013年第3期635-640,共6页 Journal of Biomedical Engineering
基金 科技部国家高技术研究发展计划(863计划)重大项目资助(2011AA02A103) 国家科技部计划攻关重点项目资助(2011BAI14B03) 重庆市科委科技计划攻关重点项目资助(CSTC2010AA5050) 中央高校基本科研业务费资助(CDJXS102300) 重庆大学大型仪器设备开放基金项目资助
关键词 内毒素 血液净化 氯甲基树脂 肝素 多黏菌素B Endotoxin Blood purification Chloromethyl polystyrene resin (PS) Heparin Polymyxin B (PMB)
  • 相关文献

参考文献15

  • 1DAVIES B, COHEN J. Endotoxin removal devices for thetreatment of sepsis and septic shock [J]. Lancet Infect Dis,2011, 11(1): 65-71.
  • 2WINTERS B D,EBERLEIN M, LEUNG J, et al. Long-term mortality and quality of life in sepsis: a systematic re-view CJ]. Crit Care Med,2010,38(5) : 1276-1283.
  • 3ONG KG, LELAND J M,ZENGKF,et al. A rapid highly-sensitive endotoxin detection system [J]. Biosensors and Bio-electronics, 2006, 21(12): 2270-2274.
  • 4何建川,邵阳,张波,邵志成.内毒素血症治疗的研究进展[J].医学研究杂志,2008,37(9):102-104. 被引量:6
  • 5MITAKA C,TOMITA M. Polymyxin B-immobilized fibercolumn hemoperfusion therapy for septic shock [J]. Shock,2011, 36(4): 332-338.
  • 6PETSCH D, ANSPACH F B. Endotoxin removal from pro-tein solutions [J]. Biotechnology, 2000,76(2-3) : 97-119.
  • 7SCHROMM A B, BRANDENBURG K,LOPPNOW H, etal. Biological activities of lipopolysaccharides are determinedby the shape of their lipid A portion [J]. Biochemistry, 2000,267(7): 2008-2013.
  • 8刘秀英,张超灿,徐卫林.甲苯胺蓝分光光度法测定肝素钠的研究[J].化学试剂,2009,31(4):271-274. 被引量:17
  • 9李娟,吴英锋,杨新林.肝素功能化生物材料的研究进展[J].有机化学,2010,30(3):359-367. 被引量:9
  • 10CRUZ D N,PERAZELLA M A,BELLOMO R, et al. Effec-tiveness of polymyxin B-immobilized fiber column in sepsis : asystematic review [J]. Crit Care, 2007, 11(2) ; R47.

二级参考文献139

共引文献34

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部